Related Experiment Video
Updated: Jul 17, 2026

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
NK cells in cancer immunotherapy: three decades of discovery
Michael Boyiadzis1, Kenneth A Foon, Ronald B Herberman
1Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute, UPMC Cancer Pavilion, 5150 Centre Avenue, Suite 572, Pittsburgh, PA 15232, USA. boyiadzism@upmc.edu
Abstract:
Natural killer cells were first described in the early 1970s on a functional basis according to their ability to lyse tumor cells in the absence of prior stimulation. Since their discovery, NK cells have been shown to have other important functions that led to the use of NK cells as a form of adoptive immunotherapy. Over the next 5-10 years, with the advances in the field of NK cells we will undoubtedly see the use of allogeneic and autologous NK cells at the forefront of cancer immunotherapy.
Insights
Natural killer (NK) cells, discovered in the 1970s, can kill tumor cells without prior activation. Their evolving functions now position NK cells as a key component of future cancer immunotherapy strategies.
Area of Science:
- Immunology
- Cancer Research
- Cell Biology
Background:
- Natural killer (NK) cells were identified in the 1970s for their innate ability to lyse tumor cells without prior sensitization.
- Beyond cytotoxicity, NK cells possess diverse immune functions relevant to therapeutic applications.
- Advances in understanding NK cell biology have paved the way for their use in cancer treatment.
Purpose of the Study:
- To review the discovery and evolving functions of Natural Killer (NK) cells.
- To highlight the potential of NK cells in adoptive immunotherapy for cancer treatment.
- To project the future role of allogeneic and autologous NK cells in oncology.
Main Methods:
- Literature review of NK cell research from discovery to present.
- Analysis of functional characterization of NK cells.
- Synthesis of current and emerging applications in cancer immunotherapy.
Main Results:
- NK cells possess inherent tumor-lysing capabilities.
- NK cell functions extend beyond initial observations, encompassing broader immune regulation.
- Significant progress has been made in harnessing NK cells for therapeutic purposes.
Conclusions:
- The multifaceted functions of NK cells underscore their therapeutic potential.
- Adoptive immunotherapy utilizing NK cells is a rapidly advancing field in cancer treatment.
- Allogeneic and autologous NK cell therapies are poised to become prominent in future cancer immunotherapy.
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...

